Correlation Between Forte Biosciences and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forte Biosciences and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Forte Biosciences and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and Acrivon Therapeutics,.
Diversification Opportunities for Forte Biosciences and Acrivon Therapeutics,
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Forte and Acrivon is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Forte Biosciences and Acrivon Therapeutics,
Given the investment horizon of 90 days Forte Biosciences is expected to generate 1.13 times more return on investment than Acrivon Therapeutics,. However, Forte Biosciences is 1.13 times more volatile than Acrivon Therapeutics, Common. It trades about 0.01 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest 2,483 in Forte Biosciences on August 25, 2024 and sell it today you would lose (883.00) from holding Forte Biosciences or give up 35.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Forte Biosciences vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Forte Biosciences |
| Acrivon Therapeutics, |
Forte Biosciences and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Forte Biosciences and Acrivon Therapeutics,
The main advantage of trading using opposite Forte Biosciences and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Forte Biosciences vs. Eliem Therapeutics | Forte Biosciences vs. HCW Biologics | Forte Biosciences vs. RenovoRx | Forte Biosciences vs. Tempest Therapeutics |
| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. RenovoRx | Acrivon Therapeutics, vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |